Sartorius Finalizes Acquisition of MatTek from BICO Group
Deal News | Jul 08, 2025 | William Blair Capital Partners
Sartorius AG, a prominent player in the life sciences and biopharmaceutical industry, has successfully completed the acquisition of MatTek, a subsidiary of the BICO Group AB. The acquisition was facilitated by William Blair Capital Partners, which acted as the financial advisor to Sartorius. The transaction was signed on April 4, 2025, and finalized on July 1, 2025. Sartorius, based in Göttingen, Germany, aims to enhance its biopharmaceutical offerings with MatTek's advanced cell-based microtissues and 3D models, which are crucial in accelerating drug development and reducing reliance on animal testing. With this acquisition, Sartorius continues its strategy of expanding its portfolio through targeted acquisitions, strengthening its global reach across the biotech and pharmaceutical sectors.
Sectors
- Biopharmaceuticals
- Life Sciences
- Financial Advisory
Geography
- Germany – Sartorius AG is based in Göttingen, Germany, and is a key participant in the transaction.
- United States – MatTek's headquarters are located in Ashland, Massachusetts, making the U.S. a significant geography in this acquisition.
- Slovakia – MatTek operates a production site in Bratislava, Slovakia, contributing to the geographical relevance of the article.
Industry
- Biopharmaceuticals – Sartorius AG operates in the biopharmaceuticals industry, providing laboratory instruments and consumables for pharmaceutical and biopharmaceutical companies.
- Life Sciences – MatTek develops human cell-based microtissues and 3D models, aligning with Sartorius's focus on innovation in life sciences research.
- Financial Advisory – William Blair Capital Partners' role as the financial advisor highlights the financial advisory sector's involvement in facilitating mergers and acquisitions.
Financials
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Sartorius AG | Acquiring Company | Company | A global leader in life sciences and biopharmaceutical solutions based in Germany. |
| MatTek | Target Company | Company | A developer of human cell-based microtissues and 3D models, part of BICO Group AB. |
| BICO Group AB | Vendor Company | Company | Parent company of MatTek, involved in selling the subsidiary. |
| William Blair Capital Partners | Financial Advisor | Company | Provided financial advisory services to Sartorius AG in the acquisition of MatTek. |